** Shares of drug and medical device maker Johnson & Johnson JNJ.N fall 1% to $152.75
** JNJ reports medical device sales of $8.02 billion for the quarter, which came in below analysts' estimates of $8.17 billion, as per LSEG data
** Sales of J&J's medical devices have missed Wall Street estimates for the past 4 quarters
** Co also flagged a $400 million impact from tariffs, mostly related to tariffs already in place for China and Mexico that could hurt its medical device business
** "We would caution that JNJ has some of the highest China exposure (~10%) in MedTech," said JP Morgan analysts
** Overall, JNJ reported Q1 profit and revenue above analysts' expectations
** As of last close, JNJ stock up 6.7% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。